View source for HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study
Jump to navigation
Jump to search
You do not have permission to edit this page, for the following reason:
You can view and copy the source of this page.
Templates used on this page: